Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development

• Dorine A. Bax ,

  Contributed equally to this work with: Dorine A. Bax, Suzanne E. Little

  Affiliation Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Suzanne E. Little ,

  Contributed equally to this work with: Dorine A. Bax, Suzanne E. Little

  Affiliation Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Nathalie Gaspar,

  Affiliations Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom, Pharmacology and New Treatments of Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France

  ⨯
• Lara Perryman,

  Affiliation Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Lynley Marshall,

  Affiliations Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom, Paediatric Oncology, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  ⨯
• Marta Viana-Pereira,

  Affiliations Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom, Life and Health Science Research Institute (ICVS), Universidade do Minho, Braga, Portugal

  ⨯
• Tania A. Jones,

  Affiliation Neuroscience Centre, Institute of Cell and Molecular Science, Bart's and The London School of Medicine & Dentistry, London, United Kingdom

  ⨯
• Richard D. Williams,

  Affiliation Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Anita Grigoriadis,

  Affiliation Breakthrough Breast Cancer Unit, Guy's Hospital, London, United Kingdom

  ⨯
• Gilles Vassal,

  Affiliation Pharmacology and New Treatments of Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France

  ⨯
• Paul Workman,

  Affiliation Pharmacology and New Treatments of Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France

  ⨯
• Denise Sheer,

  Affiliation Neuroscience Centre, Institute of Cell and Molecular Science, Bart's and The London School of Medicine & Dentistry, London, United Kingdom

  ⨯
• Rui M. Reis,

  Affiliation Life and Health Science Research Institute (ICVS), Universidade do Minho, Braga, Portugal

  ⨯
• Andrew D. J. Pearson,

  Affiliations Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom, Paediatric Oncology, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  ⨯
• Darren Hargrave,

  Affiliation Paediatric Oncology, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  ⨯
•  [ ... ],
• Chris Jones

  * E-mail: chris.jones@icr.ac.uk.

  Affiliation Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• [ view all ]
• [ view less ]